Role of the Central Cholinergic Nervous System in Motor and Non-Motor Symptoms of Parkinson's Disease.

IF 4.8 2区 医学 Q1 NEUROSCIENCES
Si-Yuan Tian, Xin Cao, Guo-Jin Liu, Ying Zi, Hui-Xian Zhu, Yi-Miao Jiang, Wei-Wei Lou, Xiao-Xia Fang, Ling Shan, Zhan Liu, Qian-Xing Zhuang
{"title":"Role of the Central Cholinergic Nervous System in Motor and Non-Motor Symptoms of Parkinson's Disease.","authors":"Si-Yuan Tian, Xin Cao, Guo-Jin Liu, Ying Zi, Hui-Xian Zhu, Yi-Miao Jiang, Wei-Wei Lou, Xiao-Xia Fang, Ling Shan, Zhan Liu, Qian-Xing Zhuang","doi":"10.2174/011570159X368923250313045859","DOIUrl":null,"url":null,"abstract":"<p><p>Parkinson's disease (PD) is a prevalent neurodegenerative disorder that is characterized by both motor and non-motor symptoms. Although dopamine agonists have been demonstrated to be efficacious in the treatment of motor symptoms, their capacity to enhance non-motor symptoms remains constrained. This suggests that additional neurotransmitter systems may be involved in the pathogenesis of PD-related symptoms. The cholinergic nervous system plays a pivotal role in the central nervous system, with various projection systems associated with diverse functions, including but not limited to learning, memory, attention, posture, balance, eye movement control, and adaptation. Nevertheless, the role of the cholinergic nervous system in the motor and non-motor impairments associated with PD remains uncertain. This review elucidates the location, projection, receptors, and effects of central cholinergic systems, as well as their role in both the motor symptoms and non-motor symptoms of PD. Additionally, it examines the crosstalk between cholinergic systems and dopaminergic systems in PD pathology. A deeper comprehension of the fundamental mechanisms of the cholinergic system in PD may facilitate the development of novel therapeutic strategies.</p>","PeriodicalId":10905,"journal":{"name":"Current Neuropharmacology","volume":" ","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Neuropharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/011570159X368923250313045859","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Parkinson's disease (PD) is a prevalent neurodegenerative disorder that is characterized by both motor and non-motor symptoms. Although dopamine agonists have been demonstrated to be efficacious in the treatment of motor symptoms, their capacity to enhance non-motor symptoms remains constrained. This suggests that additional neurotransmitter systems may be involved in the pathogenesis of PD-related symptoms. The cholinergic nervous system plays a pivotal role in the central nervous system, with various projection systems associated with diverse functions, including but not limited to learning, memory, attention, posture, balance, eye movement control, and adaptation. Nevertheless, the role of the cholinergic nervous system in the motor and non-motor impairments associated with PD remains uncertain. This review elucidates the location, projection, receptors, and effects of central cholinergic systems, as well as their role in both the motor symptoms and non-motor symptoms of PD. Additionally, it examines the crosstalk between cholinergic systems and dopaminergic systems in PD pathology. A deeper comprehension of the fundamental mechanisms of the cholinergic system in PD may facilitate the development of novel therapeutic strategies.

中枢胆碱能神经系统在帕金森病运动和非运动症状中的作用。
帕金森病(PD)是一种常见的神经退行性疾病,以运动和非运动症状为特征。虽然多巴胺激动剂已被证明在治疗运动症状方面有效,但其增强非运动症状的能力仍然有限。这表明额外的神经递质系统可能参与pd相关症状的发病机制。胆碱能神经系统在中枢神经系统中起着举足轻重的作用,不同的投射系统具有不同的功能,包括但不限于学习、记忆、注意、姿势、平衡、眼动控制和适应。然而,胆碱能神经系统在PD相关的运动和非运动损伤中的作用仍不确定。本文综述了中枢胆碱能系统的定位、投射、受体和作用,以及它们在帕金森病运动症状和非运动症状中的作用。此外,它还检查了PD病理中胆碱能系统和多巴胺能系统之间的串扰。深入了解帕金森病胆碱能系统的基本机制可能有助于开发新的治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Neuropharmacology
Current Neuropharmacology 医学-神经科学
CiteScore
8.70
自引率
1.90%
发文量
369
审稿时长
>12 weeks
期刊介绍: Current Neuropharmacology aims to provide current, comprehensive/mini reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience. The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信